Dana-Farber/Brigham and Women's Cancer Center

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Statins to Prevent Cancer Associated Blood Clots	Embolism, Embolism and Thrombosis, Thromboembolism, cancer, cardiovascular disorder, lung disorder, neoplasm, pulmonary embolism, respiratory system disorder, vascular disorder, venous thromboembolism	Recruiting	Phase 4	2026-09-16	NCT07303816
Androgen-responsive POSLUMA-guided Intra-prostatic Boost	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 2	2026-05-29	NCT07393867
Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 2	2025-11-18	NCT06364267
Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial	Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, intestinal disorder	Recruiting	Phase 2	2025-11-04	NCT06841705
High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma	Not yet recruiting	Phase 3	2024-10-16	NCT06480396

Clinical trials